Reversal of the disease signature in prurigo nodularis by blocking the itch cytokine

J Allergy Clin Immunol. 2022 Apr;149(4):1213-1215. doi: 10.1016/j.jaci.2022.02.009. Epub 2022 Feb 18.

Author

Enikö Sonkoly¹

Affiliation

¹ Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Dermatology and Venereology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden. Electronic address: eniko.sonkoly@medsci.uu.se.

PMID: 35189125
DOI: 10.1016/j.jaci.2022.02.009

No abstract available

Keywords: IL-31; IL-31RA; Prurigo nodularis; inflammation; itch; nemolizumab; transcriptome.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cytokines
Humans
Prurigo* / drug therapy
Pruritus / drug therapy

Substances

Cytokines